dr. brufsky on cdk 4/6 inihibitors in neoadjuvant breast cancer treatment
Published 7 years ago • 90 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
4:52
future directions: cdk4/6 inhibitors in breast cancer
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
1:30
dr. brufsky on genomic assays for breast cancer
-
4:01
cdk4/6 inhibitors in breast cancer: ongoing research
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer
-
7:58
cdk 4/6 inhibitors: how are they used in metastatic breast cancer treatment?
-
1:02:43
realizing the potential of cdk 4/6 inhibitor therapy in breast cancer: real-world data and evidence
-
2:07
dr ma on questions regarding treatment sequencing in cdk4/6 inhibitor–resistant breast cancer
-
2:17
dr. goetz on treatment beyond progression on cdk4/6 inhibitors in hr breast cancer
-
8:55
cdk4/6 inhibitors in hr metastatic breast cancer
-
1:20
dr. finn on new cdk 4/6 inhibitors for breast cancer
-
1:21
dr. tripathy on combination strategies with cdk4/6 inhibitors in hr breast cancer
-
1:37
dr. han on the differences between cdk 4/6 inhibitors in er breast cancer
-
3:57
cdk 4/6 inhibitor as first-line therapy for advanced breast cancer
-
4:15
hr breast cancer: factors in selecting a cdk4/6 inhibitor
-
8:28
cdk4/6 inhibition in breast cancer
-
1:47
dr. tripathy on combination strategies with cdk4/6 inhibitors in breast cancer
-
3:50
cdk4/6 inhibitors in metastatic breast cancer
-
9:36
neoadjuvant therapy for hr breast cancer